research The potential of regulatory T cell-based therapies for alopecia areata May 2023 in “Frontiers in Immunology” Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.
research Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes 2 citations , January 2026 in “Frontiers in Endocrinology” Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.
research Regulatory T cells: master orchestrators of immune tolerance and tissue homeostasis 2 citations , June 2026 in “Frontiers in Science” Regulatory T cells help control the immune system and could lead to new treatments for diseases.
research Regulatory T cells in dominant immunologic tolerance 26 citations , September 2023 in “Journal of Allergy and Clinical Immunology” Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.
research Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo January 2026 in “Journal of Investigative Dermatology” Special cells can help regrow hair in alopecia areata.